Posters

Inspiring GCT Innovation

Nearly 50 gene and cell therapy technologies profiled by Harvard Medical School inventors and clinicians who will bring technologies to patients.

2021 Posters

Cell Based Therapies for Regeneration of Ovarian Function: Biomimetic Hormones for Replacement after Ovarian Failure

Raymond Anchan, MD, PhD

Reproductive Endocrinology & Infertility Specialist, Associate Gynecologist, BWH; Assistant Professor, HMS

Macrophage Cell Therapy in Asthma

Barbara Balestrieri, MD

Assosciate Innumologist, BWH; Assistant Professo, HMS

Retinal ganglion cell replacement for Glaucoma: improving functional integration through slow-release growth factor system

Petr Baranov, MD, PhD

Assistant Scientist, Mass Eye and Ear; Assistant Professor, HMS

A Translatable Blood-Brain-Barrier-Penetrant AAV Gene Therapy Vector

Fengfeng Bei, PhD

Principal Investigator, Neurosurgery, BWH; Assistant Professor, HMS

Chimeric Antigen Ligand (CAL) T Cell Therapy for Autoimmune Disorders

Curtis Cetrulo, MD

Director, Laboratory for Cellular Immunotherapy, MGH; Associate Professor, HMS

Therapeutic potential of Antigen Specific T Regulatory cell enriched Lines (ASTRL) from Kidney Transplant Patients

Anil Chandraker, MD

Medical Director of Kidney and Pancreas Transplantation, BWH; Associate Professor, HMS

Targeting Histone Deacetylase 11 to Stimulate Optic Nerve Growth and Regeneration

DongFeng Chen, MD, PhD

Associate Scientist, Ophthalmology, Schepens Eye Research Institute, MEE; Associate Professor, HMSS

Gene Therapy to Treat Human Recessive Deafness (DFNB8/10) Caused by a TMPRSS3 Mutatio

Zheng-Yi Chen, PhD

Associate Scientist, Eaton-Peabody Laboratories, MEE; Associate Professor, HMS

Editing Stem Cells for Recurrent Hematological Malignancies Treatment

Bin Kuan Chou, PhD

Postdoctoral Fellow, Surgery, MGH

Development of Mini-Gene Therapy for Usher Syndrome Type 1F

Pedro De la Torre Marquez, PhD

Postdoctoral Researcher, Otolaryngology, Mass Eye and Ear

CNS-Targeted Gene Therapy for an Ultra-Rare Disease

Yulia Grishchuck, PhD

Center for Human Genetic Research, MGH; Assistant Professor, HMS

YJLeukin: A Novel Potent Chimeric IL2 in Cleavable or Free Form For Cancer Immunotherapy

Youssef Jounaidi, PhD

Instructor, Anaesthesia, MGH; Instructor, HMS

Development and Application of Novel CRISPR-Cas Base Editors to Model and Treat Human Diseases

Benjamin Kleinstiver, PhD

Investigator, Pathology, MGH; Assistant Professor, HMS

Development of RNA – Targeting Therapies for Malignant Brain Tumors

Anna Krichevsky, PhD

Scientist, Center for Neurologic Diseases, Neurology, BWH; Associate Professor, HMS

Optogenetic Stimulation of the Cochlear Nucleus: Implications for New Generation Auditory Implants Based on Light

Daniel Lee, MD

Director, Pediatric Otology and Neurotology, MEE; Associate Professor, HMS

CRISPR/Cas9-based genome editing approaches for RP1 associated autosomal dominant Retinitis Pigmentosa

Qin Liu, MD, PhD

Assistant Professor, Ophthalmology, MEE, HMS

Computational Technology Platform to Identify RNA-Therapeutics Targets

Guia Guffanti Masetti, PhD

Associate Neuroscientist, Neurobiology of Fear Laboratory, McLean; Assistant Professor, HMS

Targeting the Long Non-Coding RNA INCR1 to Improve Cancer Immunotherapy

Marco Mineo, PhD

Instructor in Neurosurgery, BWH

Population and Patient-Specific Off-Target Site Analysis for CRISPR Genome Editing

Luca Pinello, PhD

Associate Pathologist, MGH; Associate Professor, HMS

Novel Allogeneic B Cell Immune Therapy for Amyotrophic Lateral Sclerosis

Mark Poznansky, MD, PhD

Director, Vaccine and Immunotherapy Center, MGH; Associate Professor, HMS

Human iPSC Derived Brown Adipocyte as a Treatment for Obesity

Jyoti Rao, PhD

Postdoctoral Fellow, Pathology, BWH

Discovery of Novel Therapeutics to Treat Autoimmune Disease Through Targeting Follicular Regulatory T Cells

Peter Sage, PhD

Associate Immunologist, BWH; Associate Professor, HMS

Synthetic mRNA Nanomedicine: An Emerging Therapy for Cancer and Genetic Diseases?

Jinjun Shi, PhD

Faculty Member, Center for Nanomedicine, BWH; Associate Professor, HMS

Improving Cell Therapy Manufacturing with High Performance Inertial Microfluidics

Kyle Smith, PhD

CTO, BendBio

Olfactory Ensheathing Glia for Cancer Gene/Cell ImmunoTherapy

Bakhos Tannous, PhD

Associate Neuroscientist, Neurology, MGH; Associate Professor, HMS

Develop First-In-Class Therapeutics for Vision Loss Due to Neurodegeneration and Enhance Efficacy of Cell Transplants and Gene Therapy

Demetrios Vavvas, MD, PhD

Monte J. Wallace Ophthalmology Chair in Retina, MEE; Associate Professor, HMS

Prevention and Treatment of GvHD in Humans with B7-H3 CAR T Cells-An Unexpected Finding

Xinhui Wang, MD, PhD

Associate Immunologist, MGH; Assistant Professor, HMS

Preserving and Restoring Vision with Allogenic Cone Progenitor Cells

Michael Young, PhD

Director, Minda de Gunzburg Center for Retinal Regeneration, MEE; Associate Professor, HMS

Boston

May 2–4, 2022